BIOMARQUEURS DE DETERMINATION DE LA REPONSE CLINIQUE A UNE THERAPIE CELLULAIRE

• 收藏
• 分享

专利权人:

S.A.U;TIGENIX

发明人:

DE LA ROSA, OLGA,DALEMANS, WILFRIED

申请号：

CA2983950

公开号：

CA2983950A1

申请日:

2016.04.25

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The invention relates to a method for predicting the clinical response to a therapy based on the administration of mesenchymal stem cells (MSCs) in a patient suffering from an immune-mediated inflammatory disease. The invention also relates to methods of personalised medicine as well as to therapeutic uses of MSCs in a patient suffering from an immune-mediated inflammatory disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/